InFocus Capital Partners

Investor type Micro VC


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
The average size of a deal this fund participated in
Portfolio companies 8
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 2

Areas of investment

  • Therapeutics
  • Health Care
  • Biotechnology
  • Medical Device
  • Medical

Besides them, we counted 2 critical employees of this fund in our database.

The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the InFocus Capital Partners, startups are often financed by National Institutes of Health, ExSight Ventures, Wolfpack Investor Network. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, ExSight Ventures, Aju IB Investment. In the next rounds fund is usually obtained by Hatteras Venture Partners, ExSight Ventures, Correlation Ventures.

Among the most popular portfolio startups of the fund, we may highlight Alievio, ONL Therapeutics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical. The fund has no exact preference in some founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of InFocus Capital Partners:
Typical Co-investors
InFocus Capital Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after InFocus Capital Partners:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Abstraction Ventures Louisiana, New Orleans, United States
Agilent Ventures California, Palo Alto, United States
Arkam Ventures -
Dayang Group China, Dalian, Zhejiang
Dialog Semiconductor England, Reading, United Kingdom
Glory Technology (H.K) Group Limited -
GREYSTAR Charleston, South Carolina, United States
Gruppo Bancario Credito Valtellinese Italy, Palermo, Sicilia
JAFCO Group -
Juren Chuangtou China, Chongqing, Chongqing Shi
KIIT-TBI Bhubaneswar Municipal Corporation, India, Odisha
Linkage Biosciences California, San Francisco, United States
Lucent New Ventures Group -
Pasadera Capital San Antonio, Texas, United States
Pathena Brazil, Rio Grande do Sul, Viamão
Soleria Capital Bayern, Germany, Munich
Star Thrive Group Beijing, Beijing, China
Sumitomo Corporation Europe Limited England, London, United Kingdom
Vistaar Technologies New Jersey, Parsippany, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Stuart Therapeutics

Health Care
$11M19 Mar 2021 Florida, United States

ONL Therapeutics

$46M22 Dec 2020 Ann Arbor, Michigan, United States

Re-Vana Therapeutics

Health Care
Market Research
$3M02 Jun 2020 Northern Ireland

Mojo Vision

Big Data
Computer Vision
Health Diagnostics
Internet of Things
$51M29 Apr 2020 California, United States

ONL Therapeutics

$3M22 Aug 2019 Ann Arbor, Michigan, United States

Trefoil Therapeutics

Health Care
$28M16 Jul 2019 San Diego, California, United States


Medical Device
$1M12 Feb 2019 Palo Alto, California, United States


Health Care
Medical Device
$1M03 Jul 2018 Framingham, Massachusetts, United States


Health Care
Medical Device
$5M10 Apr 2018 Durham, North Carolina, United States
Stuart Therapeutics Raises $11M in Series A Funding

– Stuart Therapeutics from Stuart, Florida develops peptide therapeutics for ophthalmic diseases.
– The company raised $11m in Series A funding.
– The round was led by InFocus Capital Partners, with participation from the Wisconsin Alumni Research Foundation (WARF), MiMo Capital and BioBrit.
– The proceeds from the round will fund Phase 2 clinical trials for the company’s proprietary reparative therapeutic candidate, ST-100.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent InFocus Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: